SCHEMBL4764053

SCHEMBL4764053

O=c1c([N+](=O)[O-])c(/C=C/c2cnn(Cc3ccccc3F)c2)n(Cc2ccccc2F)c(=O)n1Cc1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
PKM P14618 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ADORA2B P29275 2/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
GAA P10253 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
PKLR P30613 1/20 0.35
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE1C Q14123 1/20 0.34
TSHR P16473 2/20 0.34
NPC1 O15118 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4765667 0.94 ADORA2A (0.40) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4762591 0.92 MAPT (0.37) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4762596 0.92 MAPT (0.37) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4763488 0.92 ADORA2B (0.42) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4763491 0.92 ADORA2B (0.42) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4762383 0.90 MAPT (0.42) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4762305 0.90 ADORA2B (0.39) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4762309 0.90 ADORA2B (0.39) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4767283 0.90 ADORA2A (0.35) ALDH1A1MAPTPKML3MBTL1ADORA2B
SCHEMBL4766042 0.90 ALDH1A1 (0.35) ALDH1A1MAPTPKML3MBTL1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed